Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fallopian Tube Neoplasms × cabozantinib × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 27 Osteosarcoma 5 Neuroendocrine Tumors 4 Colorectal Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Carcinoma, Hepatocellular 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Sarcoma, Ewing 3 Neoplasms 3 Melanoma 3 Kidney Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Medullary 3 Adrenocortical Carcinoma 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Brain Neoplasms 2 von Hippel-Lindau Disease 1 Wilms Tumor 1 Urachal adenocarcinoma 1

Interventions

Bevacizumab 20 Carboplatin 19 Paclitaxel 18 Specimen Handling 15 olaparib 13 Magnetic Resonance Spectroscopy 13 liposomal doxorubicin 10 Gemcitabine 9 Biopsy 9 Taxes 8 pembrolizumab 7 Doxorubicin 5 niraparib 4 cediranib 4 Immunoglobulin G 4 Drug Therapy 4 Disulfides 4 Cisplatin 4 oregovomab 3 mirvetuximab soravtansine 3 adavosertib 3 Topotecan 3 Platinum 3 Nivolumab 3 130-nm albumin-bound paclitaxel 3 rucaparib 2 cemiplimab 2 berzosertib 2 X-Rays 2 Hyperthermic Intraperitoneal Chemotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡